Research & Development

Our Clinical Pipeline

Our Clinical Pipeline

One deep-rooted belief we hold here at Enzychem Lifesciences is that any form of treatment should be accessible to patients all over the world. As we pursue to develop a global new drug, our team carries the important duty of ensuring EC-18’s efficacy backed up by comprehensive studies. Enzychem has commenced clinical trials in 2016, and since then, we have been conducting ongoing research in the drug’s effects on patients with one of various conditions.

Our Clinical Program

Our Clinical Program

The global drug development program at Enzychem entails an extensive sequence of clinical studies on the safety and efficacy of EC-18 in various indications.

Research

Research

Research is and always will be an ongoing process here at Enzychem. From published papers to presentations, all conducted research is to the visitors’ availability in chronological sequence.